Metastatic hormone-sensitive prostate cancer, or mHSPC, is a type of prostate cancer that has spread to other parts of the body and still responds to hormone therapy.*

*Hormone therapy includes drug treatments or surgery to lower testosterone.

Metastatic hormone-sensitive prostate cancerMetastatic hormone-sensitive prostate cancer

Metastatic:
has spread to other parts of the body

Hormone-sensitive:
can be treated with hormone therapy

Prostate cancer

Understanding mHSPC

A diagnosis of mHSPC can be different for everyone. Some men may find they have metastatic prostate cancer when they are diagnosed, while others may have had localized cancer that later spread beyond the prostate.

It’s important to know if your cancer has spread, as your doctor may consider a different approach to treatment.

Treatment goals in mHSPC generally include:

  • Extending life
  • Delaying disease-related pain

Ultimately, your treatment goals are personal decisions to be made between you and your care team.

For more information about mHSPC and NUBEQA